Determinants of improved one-year survival in non-ST-segment elevation myocardial infarction patients: Insights from the French FAST-MI program over 15years

0 avis

Determinants of improved one-year survival in non-ST-segment elevation myocardial infarction patients: Insights from the French FAST-MI program over 15years

Archive ouverte

Edité par CCSD ; Elsevier -

International audience. Improved early outcome in non-ST elevation myocardial infarction (NSTEMI) patients has been mainly attributed to a broader use of invasive strategies. Little is known about the impact of other changes in early management.

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Acute Myocardial Infarction

Archive ouverte | Puymirat, Etienne | CCSD

International audience. BACKGROUND: ST-segment-elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI) management has evolved considerably over the past 2 decades. Little ...

Factors Associated with Infarct-related Artery Patency before Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction (From the FAST-MI 2010 Registry)

Archive ouverte | Bailleul, Clotilde | CCSD

International audience. Early infarct-related artery (IRA) patency is associated with better clinical outcomes in patients with ST-elevation myocardial infarction (STEMI). Using the French Registry of ST-elevation a...

Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry.

Archive ouverte | Simon, Tabassome | CCSD

International audience. BACKGROUND: Clopidogrel requires metabolic activation by cytochrome P450 2C19 (CYP2C19). Proton pump inhibitors (PPIs) that inhibit CYP2C19 are commonly coadministered with clopidogrel to red...

Chargement des enrichissements...